Listen in on our conversation with Rob Etherington, CEO of Clene Nanomedicine, a company pioneering nanotherapeutics for neurodegenerative diseases like ALS, multiple sclerosis, and Parkinson's.
Rob discusses Clene's unique approach to improve mitochondrial function through a novel...
Published 04/24/24